Evidence-Based Medicine Guidelines
Serotonin reuptake inhibitors for premenstrual syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Serotonin Reuptake Inhibitors for Premenstrual Syndrome." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456477/all/Serotonin_reuptake_inhibitors_for_premenstrual_syndrome.
Serotonin reuptake inhibitors for premenstrual syndrome. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456477/all/Serotonin_reuptake_inhibitors_for_premenstrual_syndrome. Accessed November 3, 2024.
Serotonin reuptake inhibitors for premenstrual syndrome. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456477/all/Serotonin_reuptake_inhibitors_for_premenstrual_syndrome
Serotonin Reuptake Inhibitors for Premenstrual Syndrome [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 November 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456477/all/Serotonin_reuptake_inhibitors_for_premenstrual_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Serotonin reuptake inhibitors for premenstrual syndrome
ID - 456477
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456477/all/Serotonin_reuptake_inhibitors_for_premenstrual_syndrome
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
